Controlled Release Drug Delivery Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Controlled Release Drug Delivery Market- Key Findings, 2020

3. Strategic Imperatives on Global Controlled Release Drug Delivery Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Controlled Release Drug Delivery Companies

4. Controlled Release Drug Delivery Market Value Outlook to 2026, by Technology

• 4.1 Wurster technique
• 4.2 Coacervation
• 4.3 Micro Encapsulation
• 4.4 Implants
• 4.5 Transdermal
• 4.6 Targeted Delivery
• 4.7 Microelectromechanical Technology
• 4.8 Others

5. Controlled Release Drug Delivery Market Value Outlook to 2026, by Mechanism

• 5.1 Polymer Coating Systems
• 5.2 Polymer Matrix Based Systems
  • 5.2.1 Hydrophilic Polymer Matrix Systems
  • 5.2.2 Lipophilic Polymer Matrix Systems
• 5.3 Micro Reservoir Partition Controlled Drug Delivery Systems
• 5.4 Feedback Regulated Drug Delivery Systems
• 5.5 Activation-modulated Drug Delivery Systems
  • 5.5.1 Mechanically Activated
    • 5.5.1.1 Osmotic Pressure Activated
    • 5.5.1.2 Hydrodynamic Pressure Activate
    • 5.5.1.3 Vapor Pressure Activated
    • 5.5.1.4 Mechanically Activated
    • 5.5.1.5 Magnetically Activated
  • 5.6 Chemically Activated
    • 5.6.1 pH Activated
    • 5.6.2 Hydrolysis Activated
    • 5.6.3 Enzyme Activated

  6. Controlled Release Drug Delivery Market Value Outlook to 2026, by Application

  • 6.1 Metered Dose Inhalers
  • 6.2 Injectable
  • 6.3 Transdermal and Ocular Patches
  • 6.4 Infusion Pumps
  • 6.5 Oral Controlled-drug delivery Systems
  • 6.6 Drug Eluting Stents
  • 6.7 Others

  7 Asia Pacific Controlled Release Drug Delivery Market Value Outlook to 2026

  • 7.1 Leading Controlled Release Drug Delivery Types contributing to Asia Pacific market
  • 7.2 Top Applications contributing to Asia Pacific Controlled Release Drug Delivery
  • 7.3 Top countries contributing to Asia Pacific Controlled Release Drug Delivery

  8 Europe Controlled Release Drug Delivery Market Value Outlook to 2026

  • 8.1 Leading Controlled Release Drug Delivery Types contributing to Europe market
  • 8.2 Top Applications contributing to Europe Controlled Release Drug Delivery
  • 8.3 Top countries contributing to Europe Controlled Release Drug Delivery

  9 North America Controlled Release Drug Delivery Market Value Outlook to 2026

  • 9.1 Leading Controlled Release Drug Delivery Types contributing to North America market
  • 9.2 Top Applications contributing to North America Controlled Release Drug Delivery
  • 9.3 Top countries contributing to North America Controlled Release Drug Delivery

  10 South and Central America Controlled Release Drug Delivery Market Value Outlook to 2026

  • 10.1 Leading Controlled Release Drug Delivery Types contributing to South and Central America market
  • 10.2 Top Applications contributing to South and Central America Controlled Release Drug Delivery
  • 10.3 Top countries contributing to South and Central America Controlled Release Drug Delivery

  11 Middle East Africa Controlled Release Drug Delivery Market Value Outlook to 2026

  • 11.1 Leading Controlled Release Drug Delivery Types contributing to Middle East Africa market
  • 11.2 Top Applications contributing to Middle East Africa Controlled Release Drug Delivery
  • 11.3 Top countries contributing to Middle East Africa Controlled Release Drug Delivery

  12 Business Profiles of Leading Companies

  • 12.1 Business Description, SWOT and Financial Analysis of Companies in Controlled Release Drug Delivery market
  • 12.2 Alkermes plc
  • 12.3 Aradigm Corporation
  • 12.4 Capsugel
  • 12.5 Coating Place, Inc.
  • 12.6 Corium International, Inc.
  • 12.7 Depomed, Inc.
  • 12.8 Johnson and Johnson Services, Inc.
  • 12.9 Merck and Co., Inc.
  • 12.10 Orbis Biosciences, Inc.
  • 12.11 Pfizer, Inc.

  13 Recent Industry Developments

  14 Appendix

  • 14.1 OGAnalysis Expertise
  • 14.2 Sources and Methodology